Electromed (NYSE:ELMD) Stock Rating Lowered by StockNews.com

Electromed (NYSE:ELMD) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday.

Electromed Stock Down 2.5 %

Shares of NYSE:ELMD opened at $28.63 on Wednesday. The firm has a fifty day simple moving average of $31.40 and a two-hundred day simple moving average of $25.17. Electromed has a 52 week low of $13.74 and a 52 week high of $35.56. The stock has a market capitalization of $245.07 million, a P/E ratio of 38.17 and a beta of 0.33.

Insiders Place Their Bets

In other Electromed news, Director Kathleen Skarvan sold 8,640 shares of Electromed stock in a transaction on Friday, February 14th. The shares were sold at an average price of $32.25, for a total transaction of $278,640.00. Following the completion of the transaction, the director now directly owns 71,576 shares of the company’s stock, valued at $2,308,326. The trade was a 10.77 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Andrew Summers sold 12,731 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the transaction, the director now owns 165,755 shares in the company, valued at $4,969,334.90. This trade represents a 7.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 77,788 shares of company stock valued at $2,326,350 over the last ninety days. 14.00% of the stock is owned by insiders.

Institutional Trading of Electromed

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ELMD. Russell Investments Group Ltd. purchased a new position in shares of Electromed during the fourth quarter valued at approximately $37,000. IFP Advisors Inc bought a new stake in shares of Electromed during the 4th quarter worth approximately $59,000. Quantbot Technologies LP purchased a new position in Electromed during the 4th quarter valued at $99,000. Bank of America Corp DE grew its position in Electromed by 179.2% in the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock valued at $118,000 after acquiring an additional 2,570 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Electromed in the fourth quarter worth $119,000. 40.82% of the stock is owned by hedge funds and other institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.